The Food and Drug Administration Advisory Committee is scheduled to meet on December 10 to discuss Fifazer Inc Insurance’s emergency use request.
WASHINGTON (Reuters) – The first vaccines could be launched on December 12, according to the US Department of Health and Human Services.
The Food and Drug Administration Advisory Committee is scheduled to meet on December 10 to request an emergency use of the COVID-19 vaccine.
Pfizer and German partner Bioentech recently announced that the vaccine is 95% effective in preventing moderate to severe COVID-19 infection.
Dr. Monsef Slawi, head of Operation War Speed, said he plans to send vaccines to states within 24 hours of being approved by the FDA.
Slavoi told CNN that he expects the vaccinations to start on December 12, the second day.
Pfizer will allow U.S. regulators to use the COVID-19 vaccine, which was officially requested on Friday, to start the process early in the month, which could lead to limited first vaccines, and eventually end the epidemic – but not for long, severe winters.
With the rise of coronavirus in the United States and around the world, regulators are pushing for faster decisions.
For his part, Dr. Anthony Faui, a senior infectious disease specialist in the United States, said it was time to give up masks and other precautionary measures on the eve of Fifa’s announcement. We really need to double the public health measures as we wait for that help to come.
Friday’s registration will trigger a chain of events as the FDA and independent advisers argue if the bullets are ready. If so, then another government group must decide how to provide limited limited resources to Americans who are looking forward to it.
How many vaccines are available and when they will be targeted, but initial supplies will be scarce and affordable. Globally, Pfizer estimates that 50 million doses will be available by the end of the year.
Lauren Nergard contributed to this report.